Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDr. Reddy`s Laboratories Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $11.11 | $11.53 | $11.28 |
| Q2 2026 | 1 | $8.61 | $8.94 | $8.75 |
| Q3 2026 | 1 | $9.17 | $9.52 | $9.32 |
| Q4 2026 | 1 | $11.85 | $12.30 | $12.04 |
| Q1 2027 | 1 | $11.89 | $12.34 | $12.07 |
| Q2 2027 | 1 | $13.21 | $13.71 | $13.42 |
| Q3 2027 | 1 | $14.58 | $15.14 | $14.81 |
| Q4 2027 | 1 | $15.83 | $16.43 | $16.08 |
| Q1 2028 | 1 | $16.44 | $17.07 | $16.70 |
Dr. Reddy`s Laboratories Ltd. Earnings Date And Information
Dr. Reddy`s Laboratories Ltd. last posted its earnings results on Friday, October 23rd, 2026. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.09679 by $0.02321. The company had revenue of 86.59 B for the quarter and had revenue of 353.47 B for the year. Dr. Reddy`s Laboratories Ltd. has generated $54 earnings per share over the last year ($53.92 diluted earnings per share) and currently has a price-to-earnings ratio of 40.86. Dr. Reddy`s Laboratories Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Dr. Reddy`s Laboratories Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/23/2026 | Q2 2027 | $0.10 | $11.45 | 11.35 | $86.14 B | $86.59 B |
| 07/22/2026 | Q1 2027 | N/A | $5.35 | N/A | $81.02 B | $81.18 B |
| 05/12/2026 | Q4 2026 | N/A | $2.68 | N/A | $84.03 B | $76.33 B |
| 01/21/2026 | Q3 2026 | N/A | $14.53 | N/A | $83.34 B | $87.27 B |
| 10/24/2025 | Q2 2026 | $0.18 | $17.27 | 17.09 | $86.96 B | $88.05 B |
| 06/30/2025 | Q1 2026 | N/A | $17.04 | N/A | $86.74 B | $85.45 B |
| 06/06/2025 | Q4 2025 | N/A | $19.13 | N/A | $83.67 B | $85.06 B |
| 12/31/2024 | Q3 2025 | N/A | $16.96 | N/A | $81.15 B | $83.59 B |
| 09/30/2024 | Q2 2025 | N/A | $15.06 | N/A | $77.12 B | $80.16 B |
| 06/30/2024 | Q1 2025 | N/A | $16.69 | N/A | $72.98 B | $76.73 B |
| 06/12/2024 | Q4 2024 | N/A | $15.70 | N/A | $70.64 B | $70.83 B |
| 06/12/2024 | Q3 2024 | N/A | $16.56 | N/A | $69.17 B | $72.15 B |
| 09/30/2023 | Q2 2024 | N/A | $17.79 | N/A | $67.88 B | $832.20 M |
| 06/30/2023 | Q1 2024 | N/A | $84.38 | N/A | $63.79 B | $67.38 B |
| 06/13/2023 | Q4 2023 | N/A | $57.60 | N/A | $61.20 B | $765.60 M |
| 06/13/2023 | Q3 2023 | N/A | $75.09 | N/A | $59.36 B | $67.70 B |
| 09/30/2022 | Q2 2023 | N/A | $67.40 | N/A | $56.69 B | $790.11 M |
| 06/30/2022 | Q1 2023 | N/A | $71.56 | N/A | $53.61 B | $52.15 B |
| 06/27/2022 | Q4 2022 | N/A | $5.28 | N/A | $51.44 B | $722.59 M |
| 12/31/2021 | Q3 2022 | N/A | $42.58 | N/A | $54.61 B | $53.20 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dr. Reddy`s Laboratories Ltd. Earnings: FAQ's
In the previous quarter, Dr. Reddy`s Laboratories Ltd. (:RDY) reported $0.12 earnings per share (EPS) to beat the analysts' consensus estimate of $0.09679 by $0.02321.
The conference call for Dr. Reddy`s Laboratories Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Dr. Reddy`s Laboratories Ltd.'s latest earnings report can be read online.
Dr. Reddy`s Laboratories Ltd. (:RDY) has a recorded annual revenue of $353.47 B.
Dr. Reddy`s Laboratories Ltd. (:RDY) has a recorded net income of $45.09 B.Dr. Reddy`s Laboratories Ltd. has generated $53.92 earnings per share over the last four quarters.
Dr. Reddy`s Laboratories Ltd. (:RDY) has a price-to-earnings ratio of 40.86 and price/earnings-to-growth ratio is -0.78.